BNP Paribas Knock-Out MRK/ DE000PC24LZ3 /
7/17/2024 5:05:21 PM | Chg.-0.020 | Bid5:10:25 PM | Ask5:10:25 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.040EUR | -0.49% | 4.060 Bid Size: 39,000 |
4.070 Ask Size: 39,000 |
Merck and Co Inc | 169.6418 USD | 12/31/2078 | Put |
GlobeNewswire
6/11
Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire
6/6
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire
5/28
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
5/23
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
5/16
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/14
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
5/8
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
4/24
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...
GlobeNewswire
4/15
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire
4/9
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...